References Pope C
Rybelsus belongs to a class of medicines known as glucagon-like peptide-1 (GLP-1) receptor agonists It works by stimulating the pancreas to release insulin when glucose levels are high Rybelsus is usually not the first choice of medication for treating diabetes, and its not used to treat type 1 diabetes Its not known if Rybelsus is safe and effective for use in people under 18 years of age It is not known if Rybelsus can be used safely in people with pancreatitis Before starting treatment with Rybelsus, tell your doctor if you (or a family member) have thyroid gland issues Rybelsus most common side effects are weight loss, loss of appetite, nausea, vomiting, constipation, diarrhea, stomach pain Please refer to the originators website to learn all the information needed to use this medicine safely and effectively.
Most clinical guidance suggests treating obesity as a chronic condition requiring ongoing management
Reduced mobility due to side effects or rapid weight loss could increase venous stasis
Unlike phentermine, GLP-1 medications are approved for long-term, chronic use
Realistic expectations are essentialthis is not a magic bullet for rapid dramatic weight loss